Filter News
Area of Research
- (-) Isotopes (9)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (17)
- Computational Biology (2)
- Computational Engineering (1)
- Energy Science (13)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (27)
- Fusion Energy (10)
- Isotope Development and Production (1)
- Materials (23)
- Materials for Computing (2)
- National Security (7)
- Neutron Science (17)
- Nuclear Science and Technology (38)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (21)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 9 of 9 Results
After retiring from Y-12, Scott Abston joined the Isotope Science and Engineering Directorate to support isotope production and work with his former manager. He now leads a team maintaining critical equipment for medical and space applications. Abston finds fulfillment in mentoring his team and is pleased with his decision to continue working.

Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.

In June, ORNL hit a milestone not seen in more than three decades: producing a production-quality amount of plutonium-238

Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.

As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.

A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.

Brian Damiano, head of the Centrifuge Engineering and Fabrication Section, has been elected fellow of the American Society of Mechanical Engineers.

East Tennessee occupies a special place in nuclear history. In 1943, the world’s first continuously operating reactor began operating on land that would become ORNL.

When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.